← Gregory D. Lewis

Papers by Gregory D. Lewis

Page 1 · newest first

1. Iron Repletion in Heart Failure With Preserved Ejection Fraction: The IRONMET-HFpEF Randomized TrialCirculation · 2026
2. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology · 2021
3. Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in HFpEFJACC Heart Failure · 2025
4. Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of AmericaJournal of Cardiac Failure · 2023
5. Cardiovascular Phenotype in HFpEF Patients With or Without DiabetesJournal of the American College of Cardiology · 2014
6. Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency SyndromeJournal of the American College of Cardiology · 2022
7. Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic CardiomyopathyJAMA Cardiology · 2025
8. Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor HeartsJACC Heart Failure · 2026
9. Bioactive Lipids of Cardiorespiratory Fitness Insights From Exercise Models in Humans, Mice, and Burmese PythonsCirculation Genomic and Precision Medicine · 2026
10. Hemodynamic and Clinical Performance of Hearts Donated After Circulatory DeathJournal of the American College of Cardiology · 2022
11. Real-World Evaluation of Recombinant Zoster Vaccine Uptake and Outcomes in Solid Organ Transplant Recipients: A Retrospective Cohort StudyAmerican Journal of Transplantation · 2026
12. Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic CardiomyopathyCirculation · 2026
13. Aficamten for Symptomatic Nonobstructive Hypertrophic CardiomyopathyNew England Journal of Medicine · 2026
14. Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCMCirculation · 2026
15. Application of Metabolomics to Cardiovascular Biomarker and Pathway DiscoveryJournal of the American College of Cardiology · 2008
16. Regression of “Gray Zone” Exercise-Induced Concentric Left Ventricular Hypertrophy During Prescribed DetrainingJournal of the American College of Cardiology · 2012
17. Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic CardiomyopathyJAMA Cardiology · 2026
18. D28-05 A Multi-center Analysis Of The Clinical And Prognostic Value Of Pulmonary Arterial Wedge Pressure To Cardiac Output Slope And Peak Pulmonary Arterial Wedge Pressure In Patients With Dyspnea On EffortAmerican Journal of Respiratory and Critical Care Medicine · 2026
19. Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary HypertensionJournal of the American College of Cardiology · 2016
20. Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on EffortJournal of the American College of Cardiology · 2020
21. Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive AssayJournal of the American College of Cardiology · 2011
22. Normative cardiopulmonary exercise data for endurance athletes: the Cardiopulmonary Health and Endurance Exercise Registry (CHEER)European Journal of Preventive Cardiology · 2021
23. Heart failure and preserved ejection fraction: pathophysiology, clinical assessment, and management of exercise intoleranceEuropean Heart Journal · 2026
24. Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection FractionCirculation · 2026
25. A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart TransplantationASAIO Journal · 2025
26. The role of bioactive lipids and eicosanoid metabolites in acute exercise in adults: Insights into human cardiorespiratory fitnessPhysiological Reports · 2025
27. Novel markers of myocardial recovery in patients with left ventricular assist device: A cardiopulmonary exercise test and hemodynamic analysisJHLT Open · 2025
28. N-Palmitoyl Glutamine Is a Candidate Mediator of Cardiorespiratory FitnessCirculation · 2025
29. Transpulmonary eicosanoid metabolite gradients: insights into metabolic flux of pro- and anti-inflammatory metabolites and lung functionERJ Open Research · 2025
30. Physical Activity by Accelerometer Inversely Associated With Liver Fibrosis; Cross‐Sectional Analysis of a Longitudinal CohortLiver International · 2025
31. Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM TrialCirculation · 2025
32. Mechanisms of reduced exercise capacity in breast cancer survivors compared to patients with HFpEF and controls: insights from comprehensive cardiopulmonary exercise testingEuropean Heart Journal Supplements · 2025
33. Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐AnalysisJournal of the American Heart Association · 2025
34. Physiologic Phenotyping of Responses to Exercise and Activity in Heart FailureCirculation Research · 2025
35. Response by Tang et al to Letter Regarding Article, “Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis”Circulation Heart Failure · 2025
36. 2098-LB: Cardiopulmonary Fitness in Adults with Type 1 DiabetesDiabetes · 2025
37. Outcomes of donation after brain death heart transplantation from older donors: A contemporary analysis of the UNOS databaseJHLT Open · 2025
38. Blood Pressure Responses During Exercise Were Associated With Average Home Blood Pressure and Home Blood Pressure Variability: The Electronic Framingham Heart StudyJournal of the American Heart Association · 2025
39. Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001JACC Heart Failure · 2025
40. Trans‐right ventricle metabolite gradients in obesity highlight multiple metabolic pathwaysPhysiological Reports · 2025
41. Peak Oxygen Uptake Vs Ventilatory Efficiency—In ReplyENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025
42. Novel Controlled Metabolic Accelerator for Obesity-Related HFpEFJAMA Cardiology · 2025
43. Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing SubanalysisCirculation Heart Failure · 2025
44. Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID TrialJournal of Cardiac Failure · 2025
45. Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the CommunityLiver International · 2024
46. Prognostic relevance of Exercise Pulmonary Hypertension: Results of the multi-center PEX-NET Clinical Research CollaborationEuropean Respiratory Journal · 2024
47. Impairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney DysfunctionClinical Journal of the American Society of Nephrology · 2024
48. Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory DeathJournal of the American Heart Association · 2024
49. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic CardiomyopathyENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2024
50. Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection FractionJAMA Cardiology · 2024